Skip to main content
Back to Notices

Archive: deadline passed on 12/01/2025

You are viewing an archived tender. Sign up free to search current tenders or browse older ones at no cost.

Completed

Bremen - Open-House-Verträge für Wirkstoffe

Buyer:
Beschaffungsamt des BMI
Region:
Bremen, DEU
Published:
12/11/2023
Deadline
12/01/2025Expired

Timeline

  1. Published
  2. Submission deadline

Description

Die AOK Bremen/Bremerhaven schließt Open-House-Verträge für diverse Wirkstoffe ab. Die Verträge laufen bis zum 28.02.2026. Ein Beitritt ist jederzeit zu den gleichen Konditionen möglich. Es handelt sich nicht um ein Vergabeverfahren im Sinne der EU-Richtlinien.

Lots (36)

  • Lot LOT-0014

    Flecainid (ATC-Code: C01BC04)

  • Lot LOT-0021

    Levomethadon (ATC-Code: N07BC05, N02AC06)

  • Lot LOT-0034

    Ticagrelor (ATC-Code: B01AC24)

  • Lot LOT-0006

    Betamethason-Fusidinsäure (ATC-Code: D07CC01)

  • Lot LOT-0005

    Apixaban (ATC-Code: B01AF02)

  • Lot LOT-0017

    Hydroxycarbamid (ATC-Code: L01XX05)

  • Lot LOT-0019

    Interferon beta 1b (ATC-Code: L03AB08)

  • Lot LOT-0002

    Acetylsalicylsäure (ATC-Code: B01AC06)

  • Lot LOT-0010

    Eisen-III-hydroxid-Polymaltose-Komplex (ATC-Code: B03AC01)

  • Lot LOT-0030

    Secukinumab (ATC-Code: L04AC10)

  • Lot LOT-0036

    Urapidil (ATC-Code: C02CA06)

  • Lot LOT-0003

    Adalimumab (ATC-Code: L04AB04)

  • Lot LOT-0008

    Carbamazepin (ATC-Code: N03AF01)

  • Lot LOT-0027

    Pipamperon (ATC-Code: N05AD05)

  • Lot LOT-0028

    Prednicarbat (ATC-Code: D07AC18)

  • Lot LOT-0037

    Ustekinumab (ATC-Code: L04AC05)

  • Lot LOT-0023

    Mercaptopurin (ATC-Code: L01BB02)

  • Lot LOT-0024

    Natalizumab (ATC-Code: L04AA23)

  • Lot LOT-0011

    Eisen-II-Sulfat (ATC-Code: B03AA07)

  • Lot LOT-0009

    Ciclosporin (ATC-Code: L04AD01)

  • Lot LOT-0020

    Kombinationen (Lösungen zur parenteralen Ernährung) (ATC-Code: B05BA10)

  • Lot LOT-0022

    Levothyroxin+Natrium (ATC-Code: H03AA01)

  • Lot LOT-0012

    Enzalutamid (ATC-Code: L02BB04)

  • Lot LOT-0007

    Buserelin (ATC-Code: L02AE01)

  • Lot LOT-0004

    Ambrisentan (ATC-Code: C02KX02)

  • Lot LOT-0018

    Interferon beta 1a (ATC-Code: L03AB07)

  • Lot LOT-0032

    Tamoxifen (ATC-Code: L02BA01)

  • Lot LOT-0031

    Tafamidis (ATC-Code: N07XX08)

  • Lot LOT-0035

    Tinzaparin (ATC-Code: B01AB10)

  • Lot LOT-0025

    Pegvisomant (ATC-Code: H01AX01)

  • Lot LOT-0026

    Phenoxymethylpenicillin (ATC-Code: J01CE02)

  • Lot LOT-0013

    Fingolimod (ATC-Code: L04AA27)

  • Lot LOT-0015

    Glatirameracetat (ATC-Code: L03AX13)

  • Lot LOT-0029

    Prednison (ATC-Code: H02AB07)

  • Lot LOT-0016

    Hydrocortison (ATC-Code: H02AB09)

  • Lot LOT-0033

    Teriflunomid (ATC-Code: L04AA31)

Classification

CPV Codes
33600000Medizintechnik & Pharma
NUTS Codes
DE501

Details

Deadline
12/01/2025
Platform
Bund, TED

Contact Information

Phone
0228 99 610 1234
Address
Beschaffungsamt des BMIBrühler Str. 353119 BonnDEU

Interested in this tender?

Manage your tenders with procuris - AI-powered analysis and automatic matching.

Open in procuris
Tender695 days remaining

AOK Hessen - Rabattvereinbarungen für Fertigarzneimittel (Open-House-Modell)

Buyer:
AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Corinna Varelmann E-Mail: am-vertragsteam@he.aok.de Telefon: +49 69 6681 6259 711 Internet-Adresse(n):Hauptadresse: http://www.aok.de/hessen/
Deadline: 09/01/2028